FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1196.158.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.158/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158 |
| Version | 20190829 |
| Status | active |
| Date | 2019-08-29T05:00:24-04:00 |
| Name | MultipleMyelomaRegimenDrugs |
| Title | Multiple Myeloma Regimen Drugs |
| Realm | us |
| Authority | hl7 |
| Description | All drug components for the treatment of multiple myeloma across all regimens from NCCR 2019 |
| Purpose | (Clinical Focus: Multiple Myeloma chemo regimen drugs),(Data Element Scope: SCDGs only.),(Inclusion Criteria: All routed medication proxy for the specified regimen components (SCDG as a proxy for routed drug).),(Exclusion Criteria: None.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1196.158",
"meta": {
"versionId": "6",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Elimu Informatics Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-10"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2019-08-29"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1196.158"
}
],
"version": "20190829",
"name": "MultipleMyelomaRegimenDrugs",
"title": "Multiple Myeloma Regimen Drugs",
"status": "active",
"experimental": false,
"date": "2019-08-29T05:00:24-04:00",
"publisher": "Elimu Informatics Steward",
"description": "All drug components for the treatment of multiple myeloma across all regimens from NCCR 2019",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: Multiple Myeloma chemo regimen drugs),(Data Element Scope: SCDGs only.),(Inclusion Criteria: All routed medication proxy for the specified regimen components (SCDG as a proxy for routed drug).),(Exclusion Criteria: None.)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"filter": [
{
"property": "concept",
"op": "in",
"value": "1154535,1154531"
}
]
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"filter": [
{
"property": "concept",
"op": "in",
"value": "1154535,1154531,1163075,1156182,1160774,1302968,1721949,1160009,1726108,1369715"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:2be4f217-207d-4d64-b7de-8c6cc8ecd244",
"timestamp": "2025-05-23T19:13:14-04:00",
"total": 10,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1154531",
"display": "dexamethasone Injectable Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1154535",
"display": "dexamethasone Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1156182",
"display": "cyclophosphamide Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1160009",
"display": "bendamustine Injectable Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1160774",
"display": "doxorubicin Injectable Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1163075",
"display": "bortezomib Injectable Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1302968",
"display": "carfilzomib Injectable Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1369715",
"display": "pomalidomide Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1721949",
"display": "daratumumab Injectable Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1726108",
"display": "elotuzumab Injectable Product"
}
]
}
}